An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco

QR Code

An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco

Abdul R Shihabi,1 Essam M Moussa,2 Hania Sobierajska,3 Birgit Schmidt4 1Al Ain Centre, Dubai, United Arab Emirates; 2New Jeddah Hospital, Jeddah, Saudi Arabia; 3Etihad Airways Medical Centre, Abu Dhabi, United Arab Emirates; 4Bayer Schering Pharma AG, Leverkusen, Germany Background: The prevalence o...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shihabi AR, Moussa EM, Sobierajska H, Schmidt B
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/1549223104274878bc35fe84a2e17f12
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
par: Rosak C, et autres
Publié: (2012)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
par: Song L, et autres
Publié: (2021)

Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
par: Bruni A, et autres
Publié: (2014)

Effectiveness of Diabetes Self-Management Educational Programs For Type 2 Diabetes Mellitus Patients In Middle East Countries: A Systematic Review
par: Mikhael EM, et autres
Publié: (2020)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
par: Rigato M, et autres
Publié: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
par: Giuseppe Derosa, et autres
Publié: (2009)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
par: Kim Y, et autres
Publié: (2012)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
par: Scott D
Publié: (2013)

Insulin detemir for the treatment of obese patients with type 2 diabetes
par: Hollander PA
Publié: (2012)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
par: Colosia AD, et autres
Publié: (2013)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
par: Sosale A, et autres
Publié: (2015)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
par: Kishimoto M
Publié: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
par: Jonathan K Reynolds
Publié: (2009)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
par: Nishio S, et autres
Publié: (2015)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
par: Stanley S Schwartz
Publié: (2010)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
par: Paul Valensi
Publié: (2009)

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
par: Baptist Gallwitz
Publié: (2010)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
par: Cadegiani FA, et autres
Publié: (2016)

Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco
par: El Brini O, et autres
Publié: (2014)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
par: Mann KV, et autres
Publié: (2014)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
par: Hoimark L, et autres
Publié: (2012)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
par: Peggy Soule Odegard, et autres
Publié: (2009)

Clinical utility of fixed combinations of sitagliptin&ndash;metformin in treatment of type 2 diabetes
par: Karen Barnard, et autres
Publié: (2010)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
par: Penfornis A, et autres
Publié: (2015)

Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
par: Otieno CFF, et autres
Publié: (2017)

Saxagliptin for type 2 diabetes
par: Antonio R Chacra, et autres
Publié: (2010)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
par: Mazzilli R, et autres
Publié: (2015)

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
par: Seufert J
Publié: (2015)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
par: Maffioli P, et autres
Publié: (2011)

Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
par: Mackenzie RWA, et autres
Publié: (2014)

Management of adult diabetic ketoacidosis
par: Gosmanov AR, et autres
Publié: (2014)

SGLT-2 inhibitors and their potential in the treatment of diabetes
par: Rosenwasser RF, et autres
Publié: (2013)

Type 2 diabetes in Brazil: epidemiology and management
par: Almeida-Pititto B, et autres
Publié: (2015)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
par: Wilke T, et autres
Publié: (2019)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
par: Powell DR, et autres
Publié: (2015)